Short Interest in AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) Increases By 205.3%

AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totalling 57,100 shares, a growth of 205.3% from the December 15th total of 18,700 shares. Based on an average trading volume of 323,200 shares, the short-interest ratio is currently 0.2 days.

NASDAQ:ANPC opened at $1.17 on Friday. AnPac Bio-Medical Science has a 52 week low of $1.01 and a 52 week high of $12.09. The stock’s 50-day moving average price is $1.40 and its 200-day moving average price is $2.80.

AnPac Bio-Medical Science (NASDAQ:ANPC) last posted its earnings results on Friday, November 26th. The company reported ($0.25) EPS for the quarter. The firm had revenue of $0.69 million during the quarter, compared to analysts’ expectations of $1.64 million.

About AnPac Bio-Medical Science

AnPac Bio-Medical Science Co, Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China. It offers cancer differentiation analysis devices and physical checkup package services.

Featured Article: Range Trading

Receive News & Ratings for AnPac Bio-Medical Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AnPac Bio-Medical Science and related companies with MarketBeat.com's FREE daily email newsletter.